Skip to Main Content

In an unexpected development, two members of the Sackler family, which controls Purdue Pharma, will testify at a House hearing on Thursday about the role the company played in fueling the opioid crisis.

Former Purdue board members David Sackler and Kathe Sackler, along with Purdue chief executive officer Craig Landau, will appear virtually at the hearing scheduled by the Committee on Oversight and Reform. The committee, which investigated the drug maker and the extensive involvement of various Sackler family members in decision making, had threatened to issue subpoenas if they did not appear.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!